Hong Kong (HSI) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Jan 07, 2026

Discover Hong Kong Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the HSI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.

44 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
8049
Jilin Province Huinan Changlong Bio-pharmacy
HK$2.16-0.9%50.0%HK$1.2bn/aPE6xn/a12.6%
239
Pak Fah Yeow International
HK$2.380.4%-3.3%HK$741.7mn/aPE10.5xn/a7.8%
2633
Jacobson Pharma
HK$1.300%28.7%HK$2.6bHK$2.53PE8.6xE8.5%7.5%
2161
JBM (Healthcare)
HK$2.794.9%55.9%HK$2.3bHK$3.53PE10.5xE14.5%7.0%
3737
Zhongzhi Pharmaceutical Holdings
HK$0.8042.9%-19.2%HK$690.9mn/aPE30.2xn/a6.2%
2877
China Shineway Pharmaceutical Group
HK$9.186.7%15.3%HK$6.9bHK$8.54PE7.5xE4.8%5.7%
2348
Dawnrays Pharmaceutical (Holdings)
HK$1.20-1.6%0.8%HK$1.8bn/aPE9.2xn/a5.2%
3933
United Laboratories International Holdings
HK$11.983.4%2.9%HK$23.6bHK$17.92PE6.9xE2.2%5.2%
2005
SSY Group
HK$3.026.7%-6.5%HK$8.8bHK$3.99PE13.3xE13.2%4.8%
1666
Tong Ren Tang Technologies
HK$4.502.0%-8.2%HK$5.8bHK$6.20PE12xE16.4%4.4%
719
Shandong Xinhua Pharmaceutical
HK$6.914.9%21.2%HK$10.1bn/aPE11.2xS7.4%4.3%
6826
Shanghai Haohai Biological Technology
HK$25.705.3%1.2%HK$10.5bHK$37.13PE13.6xE21.8%4.3%
1681
Consun Pharmaceutical Group
HK$15.881.5%114.0%HK$13.3bHK$18.67PE11.9xE12.5%4.1%
3613
Beijing Tong Ren Tang Chinese Medicine
HK$8.642.1%6.9%HK$7.2bHK$10.75PE14xE13.8%4.1%
1061
Essex Bio-Technology
HK$3.954.8%41.1%HK$2.2bHK$6.84PE7.2xE13.7%3.5%
8329
Shenzhen Neptunus Interlong Bio-technique
HK$0.16-0.6%0%HK$265.1mn/aPE38.7xn/a3.4%
512
Grand Pharmaceutical Group
HK$8.072.8%80.1%HK$28.3bHK$11.61PE13.6xE12.3%3.2%
3320
China Resources Pharmaceutical Group
HK$4.623.8%-13.3%HK$29.0bHK$6.78PE9.3xE16.0%3.0%
950
Lee's Pharmaceutical Holdings
HK$1.583.9%19.7%HK$930.4mn/aPE9.5xn/a3.0%
1093
CSPC Pharmaceutical Group
HK$9.128.2%106.3%HK$104.3bHK$10.14PE23.1xE11.6%2.8%
690
Uni-Bio Science Group
HK$0.120%82.5%HK$686.7mn/aPE7.5xn/a2.4%
1349
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$3.049.4%34.5%HK$7.8bn/aPS4xn/a2.2%
867
China Medical System Holdings
HK$13.968.2%92.6%HK$33.7bHK$16.95PE18.4xE14.3%2.1%
460
Sihuan Pharmaceutical Holdings Group
HK$1.348.9%123.3%HK$12.2bHK$1.60PS5.2xE92.0%1.6%
Page 1 of 2